1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Jung, H.J. Lee, C.W. Earm, Y.E. Kim, J.I. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking To be Published 0353 Solution structure of GsMTx-4, a peptide blocker of cation-selective stretch-activated channels 10.2210/pdb1lu8/pdb pdb_00001lu8 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 4107.934 venom toxin peptide MTx4 residues 1-34 1 syn polymer GsMTx-4 no yes GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF(NH2) GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSFX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2004-01-27 1 1 2008-04-28 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id RCSB Y PDBJ 2002-05-22 REL REL This peptide was synthesized chemically. sample Additional comments about the NMR refinement can be placed here, e.g.The structures are based on a total of 630 restraints, 591 are NOE-derived distance constraints, 27 dihedral angle restraints, 12 distance restraints from hydrogen bonds, and 9 distance restraints from disulfide bonds. This structure was determined using standard 2D homonuclear techniques. The submitted confomer models are those with the lowest energy, the least restraint violations 100 20 2D NOESY DQF-COSY PE-COSY 0 3.5 ambient 288 K distance geometry simulated annealing 3 closest to the average 10mM GsMTx-4 90% H2O/10% D2O A. T. Brunger structure solution X-PLOR 3.851 refinement X-PLOR 3.851 Bruker collection XwinNMR 3.0 Bruker processing XwinNMR 3.0 600 Bruker DRX 500 Bruker DMX GLY 1 n 1 GLY 1 A CYS 2 n 2 CYS 2 A LEU 3 n 3 LEU 3 A GLU 4 n 4 GLU 4 A PHE 5 n 5 PHE 5 A TRP 6 n 6 TRP 6 A TRP 7 n 7 TRP 7 A LYS 8 n 8 LYS 8 A CYS 9 n 9 CYS 9 A ASN 10 n 10 ASN 10 A PRO 11 n 11 PRO 11 A ASN 12 n 12 ASN 12 A ASP 13 n 13 ASP 13 A ASP 14 n 14 ASP 14 A LYS 15 n 15 LYS 15 A CYS 16 n 16 CYS 16 A CYS 17 n 17 CYS 17 A ARG 18 n 18 ARG 18 A PRO 19 n 19 PRO 19 A LYS 20 n 20 LYS 20 A LEU 21 n 21 LEU 21 A LYS 22 n 22 LYS 22 A CYS 23 n 23 CYS 23 A SER 24 n 24 SER 24 A LYS 25 n 25 LYS 25 A LEU 26 n 26 LEU 26 A PHE 27 n 27 PHE 27 A LYS 28 n 28 LYS 28 A LEU 29 n 29 LEU 29 A CYS 30 n 30 CYS 30 A ASN 31 n 31 ASN 31 A PHE 32 n 32 PHE 32 A SER 33 n 33 SER 33 A PHE 34 n 34 PHE 34 A NH2 35 n 35 NH2 35 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 22 A N LYS 22 A O ASN 31 A O ASN 31 6 A A H O SER LEU 24 29 1.53 8 A A H O SER LEU 24 29 1.54 11 A A H O SER LEU 24 29 1.57 12 A A H O SER LEU 24 29 1.50 13 A A HB3 HN1 PHE NH2 34 35 1.35 13 A A H O SER LEU 24 29 1.57 15 A A O H ASN ASN 10 12 1.56 16 A A H O SER LEU 24 29 1.47 17 A A H O SER LEU 24 29 1.60 18 A A H O SER LEU 24 29 1.58 19 A A H O SER LEU 24 29 1.57 20 A A O H ASN ASN 10 12 1.58 1 A ARG 18 0.316 SIDE CHAIN 2 A ARG 18 0.274 SIDE CHAIN 3 A ARG 18 0.078 SIDE CHAIN 4 A ARG 18 0.207 SIDE CHAIN 5 A ARG 18 0.277 SIDE CHAIN 6 A ARG 18 0.276 SIDE CHAIN 7 A ARG 18 0.274 SIDE CHAIN 8 A ARG 18 0.307 SIDE CHAIN 9 A ARG 18 0.261 SIDE CHAIN 10 A ARG 18 0.318 SIDE CHAIN 11 A ARG 18 0.316 SIDE CHAIN 12 A ARG 18 0.266 SIDE CHAIN 13 A ARG 18 0.178 SIDE CHAIN 14 A ARG 18 0.264 SIDE CHAIN 15 A ARG 18 0.266 SIDE CHAIN 16 A ARG 18 0.275 SIDE CHAIN 17 A ARG 18 0.273 SIDE CHAIN 18 A ARG 18 0.296 SIDE CHAIN 19 A ARG 18 0.278 SIDE CHAIN 20 A ARG 18 0.256 SIDE CHAIN 1 A LEU 3 -85.66 -149.95 1 A TRP 6 -161.23 43.55 1 A LYS 8 -45.83 157.14 1 A ASP 13 179.33 55.68 1 A LYS 15 -153.71 13.62 1 A LYS 20 173.99 43.24 1 A CYS 23 -43.15 152.72 1 A PHE 27 -144.92 10.09 1 A PHE 32 179.28 -79.75 2 A CYS 2 -79.86 -169.03 2 A LEU 3 -97.03 -138.86 2 A GLU 4 -116.53 -164.75 2 A TRP 6 -161.01 60.08 2 A LYS 8 -43.10 158.65 2 A ASP 13 -162.32 52.97 2 A CYS 17 -43.80 163.16 2 A LYS 20 174.71 35.93 2 A CYS 23 -36.82 148.83 2 A PHE 27 -147.79 15.78 2 A ASN 31 -112.00 -141.58 2 A PHE 32 -79.44 -164.24 2 A SER 33 -110.11 -76.05 3 A CYS 2 -53.67 -170.36 3 A LEU 3 -88.18 -134.92 3 A GLU 4 -119.33 -164.43 3 A TRP 6 -161.11 49.64 3 A LYS 8 -39.30 152.35 3 A ASP 13 -148.32 49.41 3 A ASP 14 -48.41 151.54 3 A CYS 17 -46.06 152.91 3 A LYS 20 175.66 32.68 3 A CYS 23 -37.96 146.98 3 A ASN 31 -112.18 -149.26 3 A SER 33 -117.41 50.46 4 A CYS 2 -53.28 -169.84 4 A LEU 3 -94.18 -135.35 4 A TRP 6 -160.42 55.93 4 A LYS 8 -45.16 157.62 4 A ASP 13 -162.15 62.57 4 A CYS 16 -42.73 151.29 4 A CYS 17 -45.90 169.88 4 A PRO 19 -79.68 49.23 4 A LYS 20 80.96 32.36 4 A CYS 23 -38.33 148.35 4 A ASN 31 -111.80 -143.48 4 A PHE 32 -67.11 -164.25 5 A CYS 2 -54.73 -168.88 5 A GLU 4 -71.02 -165.82 5 A TRP 6 -161.15 55.50 5 A LYS 8 -45.48 153.23 5 A ASP 13 -174.69 53.47 5 A CYS 16 -44.80 154.34 5 A LYS 20 -180.00 38.91 5 A ASN 31 -116.65 -150.09 6 A CYS 2 -57.46 -169.73 6 A LEU 3 -101.16 -152.97 6 A TRP 6 -160.86 47.46 6 A LYS 8 -41.75 159.09 6 A ASP 13 -142.17 54.69 6 A CYS 17 -44.67 166.17 6 A LYS 20 168.53 34.56 6 A ASN 31 -114.03 -149.42 7 A TRP 6 -160.88 55.91 7 A LYS 8 -44.33 160.52 7 A ASP 13 -178.17 50.85 7 A ASP 14 -43.02 159.60 7 A LYS 15 -148.43 -33.47 7 A CYS 17 -52.38 -174.85 7 A ASN 31 -105.95 -140.51 8 A LEU 3 -88.08 -153.69 8 A GLU 4 -103.42 -163.85 8 A TRP 6 -162.52 43.90 8 A LYS 8 -36.31 151.59 8 A ASP 13 -151.43 47.02 8 A CYS 17 -42.26 151.47 8 A LYS 20 172.56 36.72 8 A ASN 31 -122.81 -147.67 8 A PHE 32 -64.42 -172.15 8 A SER 33 -112.47 -88.97 9 A CYS 2 33.08 -160.45 9 A LEU 3 -109.64 -141.21 9 A GLU 4 -117.73 -163.27 9 A TRP 6 -161.06 52.76 9 A LYS 8 -41.79 157.65 9 A ASP 13 -142.10 50.95 9 A LYS 20 165.07 43.70 9 A CYS 23 -35.44 149.17 9 A LYS 28 83.80 32.20 9 A ASN 31 -113.53 -141.81 10 A CYS 2 -61.06 -169.64 10 A LEU 3 -89.12 -102.44 10 A GLU 4 -163.56 -161.18 10 A TRP 6 -160.94 56.29 10 A LYS 8 -41.20 155.47 10 A PRO 11 -67.45 51.96 10 A ASN 12 -161.32 -42.27 10 A ASP 13 -147.63 48.53 10 A CYS 17 -50.85 -178.07 10 A CYS 23 -40.33 150.21 10 A PHE 27 -150.83 15.44 10 A PHE 32 166.08 -75.36 11 A CYS 2 -54.64 -167.72 11 A LEU 3 -100.43 -157.11 11 A TRP 6 -160.85 53.02 11 A LYS 8 -46.02 157.77 11 A ASP 13 -144.33 51.73 11 A CYS 16 -43.74 152.01 11 A CYS 17 -45.99 154.01 11 A LYS 20 178.65 41.38 11 A ASN 31 -112.99 -133.81 11 A SER 33 -67.00 -152.54 12 A CYS 2 -125.62 -168.69 12 A LEU 3 -84.09 -124.02 12 A GLU 4 -139.03 -157.78 12 A TRP 6 -160.72 47.51 12 A LYS 8 -40.45 156.47 12 A CYS 17 -45.09 153.32 12 A LYS 20 178.84 46.53 12 A CYS 23 -39.06 140.02 12 A LYS 28 82.66 21.70 12 A PHE 32 -175.70 -70.36 13 A GLU 4 -63.55 -169.04 13 A TRP 6 -161.61 49.81 13 A ASP 13 -170.13 54.17 13 A CYS 17 -45.04 159.95 13 A LYS 20 175.32 32.17 13 A CYS 23 -39.19 147.58 13 A PHE 32 177.45 -68.06 13 A SER 33 -60.61 -159.74 14 A CYS 2 -54.63 -171.74 14 A LEU 3 -95.48 -152.06 14 A TRP 6 -160.45 54.80 14 A LYS 8 -41.16 156.71 14 A ASP 13 -147.61 52.90 14 A ASP 14 -40.00 114.83 14 A CYS 17 -44.34 162.28 14 A LYS 20 168.32 46.57 14 A CYS 23 -44.61 156.26 14 A PHE 27 -140.17 10.43 14 A ASN 31 -100.13 -152.45 14 A SER 33 -141.83 -80.75 15 A CYS 2 -49.05 -178.60 15 A LEU 3 -78.10 -163.41 15 A TRP 6 -161.17 54.45 15 A LYS 8 -39.11 150.44 15 A PRO 11 -65.04 58.99 15 A ASN 12 -159.78 -40.90 15 A ASP 13 -153.74 45.79 15 A CYS 17 -39.97 154.77 15 A LYS 20 170.93 38.20 15 A ASN 31 -118.81 -152.79 15 A SER 33 175.30 118.64 16 A GLU 4 -75.40 -168.30 16 A TRP 6 -162.43 42.32 16 A LYS 8 -35.64 136.65 16 A CYS 17 -46.31 164.82 16 A LYS 20 170.56 53.43 16 A PHE 32 179.19 -72.46 16 A SER 33 -172.04 -164.79 17 A CYS 2 -65.89 -165.72 17 A LEU 3 -104.83 -139.76 17 A GLU 4 -113.50 -164.99 17 A TRP 6 -162.22 52.84 17 A ASP 14 -39.42 148.37 17 A LYS 15 -146.53 -30.41 17 A CYS 16 -41.88 151.45 17 A CYS 17 -51.47 179.56 17 A LYS 20 72.07 41.99 17 A LEU 26 -41.70 -82.79 17 A LYS 28 72.69 35.65 17 A ASN 31 -105.95 -138.55 18 A CYS 2 -55.77 -166.91 18 A LEU 3 -95.39 -148.58 18 A PHE 5 -59.76 -9.21 18 A TRP 6 -152.71 59.59 18 A LYS 8 -43.69 153.11 18 A ASP 13 -168.22 52.77 18 A CYS 17 -45.63 166.70 18 A LYS 20 75.32 56.71 18 A PHE 27 -142.90 14.12 18 A ASN 31 -134.82 -138.69 18 A PHE 32 -76.98 -160.86 18 A SER 33 -142.53 -37.40 19 A CYS 2 -58.06 -170.29 19 A LEU 3 -100.22 -157.43 19 A TRP 6 -161.00 53.14 19 A LYS 8 -39.96 154.57 19 A ASP 13 -167.01 53.89 19 A CYS 17 -42.73 163.97 19 A LYS 20 164.59 37.90 19 A CYS 23 -39.88 144.46 19 A ASN 31 -114.53 -145.14 20 A GLU 4 -55.01 -167.52 20 A TRP 6 -162.19 56.01 20 A LYS 8 -45.92 153.57 20 A CYS 9 -161.64 -169.40 20 A PRO 11 -66.79 55.69 20 A ASN 12 -161.13 -39.91 20 A ASP 13 -154.31 47.68 20 A CYS 17 -41.35 152.53 20 A LYS 20 172.33 34.08 20 A CYS 23 -42.37 156.75 20 A ASN 31 -114.30 -152.59 Solution structure of GsMTx-4 1 N N disulf 2.020 A CYS 2 A SG CYS 2 1_555 A CYS 17 A SG CYS 17 1_555 disulf 2.020 A CYS 9 A SG CYS 9 1_555 A CYS 23 A SG CYS 23 1_555 disulf 2.020 A CYS 16 A SG CYS 16 1_555 A CYS 30 A SG CYS 30 1_555 covale 1.380 both A PHE 34 A C PHE 34 1_555 A NH2 35 A N NH2 35 1_555 TOXIN Triple stranded antiparellel beta-sheet, inhibitory cystine knot, TOXIN AAP79435 GB 1 47 32309340 GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF 47 80 1LU8 1 34 32309340 A 1 1 34 2 anti-parallel A LEU 21 A LEU 21 A SER 24 A SER 24 A LEU 29 A LEU 29 A PHE 32 A PHE 32 BINDING SITE FOR RESIDUE NH2 A 35 A NH2 35 Software 2 A LEU 21 A LEU 21 2 1_555 A PHE 34 A PHE 34 2 1_555